COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss

Eujin Park, Yo Han Ahn, Hee Gyung Kang, Kee Hwan Yoo, Nam Hee Won, Kyoung Bun Lee, Kyung Chul Moon, Moon Woo Seong, Tae rin Gwon, Sung Sup Park, Hae Il Cheong

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The phenotypic combination of steroid-resistant focal segmental glomerulosclerosis (SR-FSGS) and sensorineural hearing loss has been mainly reported in patients with mitochondrial cytopathies, including primary coenzyme Q10 (CoQ10) deficiency. In this report of 10 children with SR-FSGS and sensorineural hearing loss, we found 6 patients with biallelic COQ6 mutations. Median age at the onset of nephrotic syndrome was 29 (range, 15-47) months. All patients progressed to end-stage renal disease within a median of 13 (range, 1-27) months after the onset. Kidney biopsy revealed abnormal mitochondrial proliferation in podocytes in all 6 patients. None of the 5 patients who underwent kidney transplantation developed recurrence of FSGS. Primary CoQ10 deficiency due to COQ6 mutations should be considered in children presenting with both SR-FSGS and sensorineural hearing loss. An early diagnosis of COQ6 mutations is essential because the condition is treatable when CoQ10 supplementation is started at the early stage. We recommend early kidney biopsy because detection of abnormal mitochondrial proliferation in podocytes might provide an earlier diagnostic clue.

Original languageEnglish
Pages (from-to)139-144
Number of pages6
JournalAmerican Journal of Kidney Diseases
Volume70
Issue number1
DOIs
Publication statusPublished - 2017 Jul 1

Fingerprint

Focal Segmental Glomerulosclerosis
Sensorineural Hearing Loss
Steroids
Mutation
Podocytes
coenzyme Q10
Kidney
Biopsy
Nephrotic Syndrome
Age of Onset
Kidney Transplantation
Chronic Kidney Failure
Early Diagnosis
Recurrence

Keywords

  • case report
  • children
  • coenzyme Q10 deficiency
  • COQ6 mutation
  • end-stage renal disease (ESRD)
  • kidney biopsy
  • mitochondrial cytopathy
  • mitochondrial proliferation in podocytes
  • pediatric
  • sensorineural hearing loss
  • Steroid-resistant focal segmental glomerulosclerosis (SR-FSGS)

ASJC Scopus subject areas

  • Nephrology

Cite this

COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss. / Park, Eujin; Ahn, Yo Han; Kang, Hee Gyung; Yoo, Kee Hwan; Won, Nam Hee; Lee, Kyoung Bun; Moon, Kyung Chul; Seong, Moon Woo; Gwon, Tae rin; Park, Sung Sup; Cheong, Hae Il.

In: American Journal of Kidney Diseases, Vol. 70, No. 1, 01.07.2017, p. 139-144.

Research output: Contribution to journalArticle

Park, E, Ahn, YH, Kang, HG, Yoo, KH, Won, NH, Lee, KB, Moon, KC, Seong, MW, Gwon, TR, Park, SS & Cheong, HI 2017, 'COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss', American Journal of Kidney Diseases, vol. 70, no. 1, pp. 139-144. https://doi.org/10.1053/j.ajkd.2016.10.040
Park, Eujin ; Ahn, Yo Han ; Kang, Hee Gyung ; Yoo, Kee Hwan ; Won, Nam Hee ; Lee, Kyoung Bun ; Moon, Kyung Chul ; Seong, Moon Woo ; Gwon, Tae rin ; Park, Sung Sup ; Cheong, Hae Il. / COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss. In: American Journal of Kidney Diseases. 2017 ; Vol. 70, No. 1. pp. 139-144.
@article{ad9bcaff491a4c73953c9b4dca6c0aa7,
title = "COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss",
abstract = "The phenotypic combination of steroid-resistant focal segmental glomerulosclerosis (SR-FSGS) and sensorineural hearing loss has been mainly reported in patients with mitochondrial cytopathies, including primary coenzyme Q10 (CoQ10) deficiency. In this report of 10 children with SR-FSGS and sensorineural hearing loss, we found 6 patients with biallelic COQ6 mutations. Median age at the onset of nephrotic syndrome was 29 (range, 15-47) months. All patients progressed to end-stage renal disease within a median of 13 (range, 1-27) months after the onset. Kidney biopsy revealed abnormal mitochondrial proliferation in podocytes in all 6 patients. None of the 5 patients who underwent kidney transplantation developed recurrence of FSGS. Primary CoQ10 deficiency due to COQ6 mutations should be considered in children presenting with both SR-FSGS and sensorineural hearing loss. An early diagnosis of COQ6 mutations is essential because the condition is treatable when CoQ10 supplementation is started at the early stage. We recommend early kidney biopsy because detection of abnormal mitochondrial proliferation in podocytes might provide an earlier diagnostic clue.",
keywords = "case report, children, coenzyme Q10 deficiency, COQ6 mutation, end-stage renal disease (ESRD), kidney biopsy, mitochondrial cytopathy, mitochondrial proliferation in podocytes, pediatric, sensorineural hearing loss, Steroid-resistant focal segmental glomerulosclerosis (SR-FSGS)",
author = "Eujin Park and Ahn, {Yo Han} and Kang, {Hee Gyung} and Yoo, {Kee Hwan} and Won, {Nam Hee} and Lee, {Kyoung Bun} and Moon, {Kyung Chul} and Seong, {Moon Woo} and Gwon, {Tae rin} and Park, {Sung Sup} and Cheong, {Hae Il}",
year = "2017",
month = "7",
day = "1",
doi = "10.1053/j.ajkd.2016.10.040",
language = "English",
volume = "70",
pages = "139--144",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss

AU - Park, Eujin

AU - Ahn, Yo Han

AU - Kang, Hee Gyung

AU - Yoo, Kee Hwan

AU - Won, Nam Hee

AU - Lee, Kyoung Bun

AU - Moon, Kyung Chul

AU - Seong, Moon Woo

AU - Gwon, Tae rin

AU - Park, Sung Sup

AU - Cheong, Hae Il

PY - 2017/7/1

Y1 - 2017/7/1

N2 - The phenotypic combination of steroid-resistant focal segmental glomerulosclerosis (SR-FSGS) and sensorineural hearing loss has been mainly reported in patients with mitochondrial cytopathies, including primary coenzyme Q10 (CoQ10) deficiency. In this report of 10 children with SR-FSGS and sensorineural hearing loss, we found 6 patients with biallelic COQ6 mutations. Median age at the onset of nephrotic syndrome was 29 (range, 15-47) months. All patients progressed to end-stage renal disease within a median of 13 (range, 1-27) months after the onset. Kidney biopsy revealed abnormal mitochondrial proliferation in podocytes in all 6 patients. None of the 5 patients who underwent kidney transplantation developed recurrence of FSGS. Primary CoQ10 deficiency due to COQ6 mutations should be considered in children presenting with both SR-FSGS and sensorineural hearing loss. An early diagnosis of COQ6 mutations is essential because the condition is treatable when CoQ10 supplementation is started at the early stage. We recommend early kidney biopsy because detection of abnormal mitochondrial proliferation in podocytes might provide an earlier diagnostic clue.

AB - The phenotypic combination of steroid-resistant focal segmental glomerulosclerosis (SR-FSGS) and sensorineural hearing loss has been mainly reported in patients with mitochondrial cytopathies, including primary coenzyme Q10 (CoQ10) deficiency. In this report of 10 children with SR-FSGS and sensorineural hearing loss, we found 6 patients with biallelic COQ6 mutations. Median age at the onset of nephrotic syndrome was 29 (range, 15-47) months. All patients progressed to end-stage renal disease within a median of 13 (range, 1-27) months after the onset. Kidney biopsy revealed abnormal mitochondrial proliferation in podocytes in all 6 patients. None of the 5 patients who underwent kidney transplantation developed recurrence of FSGS. Primary CoQ10 deficiency due to COQ6 mutations should be considered in children presenting with both SR-FSGS and sensorineural hearing loss. An early diagnosis of COQ6 mutations is essential because the condition is treatable when CoQ10 supplementation is started at the early stage. We recommend early kidney biopsy because detection of abnormal mitochondrial proliferation in podocytes might provide an earlier diagnostic clue.

KW - case report

KW - children

KW - coenzyme Q10 deficiency

KW - COQ6 mutation

KW - end-stage renal disease (ESRD)

KW - kidney biopsy

KW - mitochondrial cytopathy

KW - mitochondrial proliferation in podocytes

KW - pediatric

KW - sensorineural hearing loss

KW - Steroid-resistant focal segmental glomerulosclerosis (SR-FSGS)

UR - http://www.scopus.com/inward/record.url?scp=85009799038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009799038&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2016.10.040

DO - 10.1053/j.ajkd.2016.10.040

M3 - Article

C2 - 28117207

AN - SCOPUS:85009799038

VL - 70

SP - 139

EP - 144

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 1

ER -